11. Which of the following is not a regulatory authority for pharmaceuticals?
a) FDA (Food and Drug Administration)
b) EMA (European Medicines Agency)
c) CDC (Centers for Disease Control and Prevention)
d) MHRA (Medicines and Healthcare products Regulatory Agency)
12. The process of discovering and developing new drugs is often referred to as:
a) Pharmacovigilance
b) Clinical trials
c) Drug registration
d) Drug discovery
13. Which of the following is not a common route of drug administration?
a) Oral
b) Topical
c) Intravenous
d) Intramuscular
14. The process of evaluating the safety and efficacy of a drug in humans is called:
a) Preclinical testing
b) Phase 1 clinical trial
c) Post-marketing surveillance
d) Regulatory approval
15. The abbreviation “API” in the pharmaceutical industry stands for:
a) Active pharmaceutical ingredient
b) Advanced production infrastructure
c) Association of pharmaceutical industries
d) Automated packaging and labeling
